ChiRhoClin, Inc.

It has been an outstanding week and celebratory cruise. Thank you, ChiRhoClin team, for your tireless efforts and commitment. The past two years have been challenging yet fulfilling. Your collective efforts have made a significant impact on thousands of patients suffering from pancreatic diseases.

Heading home from The National Pancreas Foundation fellowship symposium. Had a great time learning about the pancreas and encouraging young researchers to join the battle against pancreatic disease, pancreatitis, and pancreatic cancer. There's a lot of hope for the future. #PancreasResearch #FutureHope

In 2025, our marketing campaign centers on the elegant and clinically powerful way human secretin stimulates the pancreas—enabling multiple diagnostic approaches to evaluate pancreatic function and detect disease, including pancreatic cancer. If you’re looking to diagnose the pancreas with accuracy and confidence, secretin is the key. We’re excited to revisit a theme from one of our most memorable campaigns: “Turn on the Pancreas.” Now, with enhanced visuals and a renewed focus on Precision Pancreatic Stimulation (PPS), we’re blending our legacy with innovation to reflect today’s advancements in precision medicine. ChiRhoStim® (Human Secretin for Injection) is designed to support your clinical decisions with clarity, confidence, and precision. We look forward to partnering with you to advance precision diagnostics and improve patient outcomes. Sincerely, Skip Purich C.E.O. https://lnkd.in/eutsTNR5

Honoring Dr. Conwell for Black History Month ChiRhoClin proudly recognizes Dr. Conwell’s contributions to medicine and his dedication to advancing healthcare. His leadership and commitment to excellence continue to inspire future generations. This Black History Month, we celebrate his impact and the path he paves for innovation and equity in healthcare. #BlackHistoryMonth #LeadershipInMedicine https://lnkd.in/eXsn6Yt9

On this Rare Disease Day, ChiRhoClin proudly stands with patients, caregivers, and healthcare professionals to raise awareness and support for those affected by rare diseases, including gastrinoma and other rare pancreatic disorders. We recognize the challenges faced by individuals living with these conditions and remain committed to advancing research, education, and innovative solutions that improve diagnosis and treatment. Together, we advocate for increased awareness, earlier detection, and better patient outcomes. No one should face a rare disease alone—ChiRhoClin stands with the rare disease community today and every day. #RareDiseaseDay https://lnkd.in/efni36Dz

In Loving Memory of Dr. Edward D. Purich Dr. Edward D. Purich, born on August 21, 1941, in Farrell, Pennsylvania, to Edward S. Purich and Violet S. Purich, passed away on February 13, 2025. The oldest of six siblings, Dr. Purich is survived by his loving wife of 56 years, Jean C. Purich; his children and their spouses, Anna and (Bryan) Allnutt and Skip and (Cynthia) Purich; his grandchildren, Jason Allnutt, Jake Allnutt, Zachary Purich, and Layla Purich; and his great-grandchildren, Levi Allnutt and Ella Allnutt. https://lnkd.in/eVxG6xFc

Merry Christmas and Happy Holidays! We’re excited to share our final newsletter of the year, featuring highlights from the successful meeting at the American Pancreatic Association conference in Hawaii. Congratulations to Dr. Venkata Akshintala on his pancreatitis research grant achievement! Wishing everyone a joyful and restful holiday season. https://lnkd.in/eQCkRw_z

Today marks World Pancreatic Cancer Awareness Day—a reminder of the critical importance of early detection in combating this devastating disease. Every day, we are committed to advancing early diagnostic efforts, collaborating with leading medical centers and dedicated physicians across the country who are courageously tackling pancreatic cancer. Together, we are making strides, and breakthroughs are within reach.💜 https://lnkd.in/ezRVhXSX

We are thrilled to announce that ChiRhoStim® (Human Secretin) will have a reliable, steady supply for years to come, thanks to our new facility at PCI. A heartfelt thank you to everyone who contributed to ensuring the availability of this essential drug. Your dedication makes a difference! https://lnkd.in/gycMFYvb

Opening night at NASPGHAN marked an exciting step forward in the fight against pancreatic disease, as ChiRhoClin, Inc. joined leading healthcare professionals to advance early diagnostic methods using Secretin. Our goal is to empower doctors with the knowledge and tools they need to identify pancreatic disease earlier and with greater, we aim to bridge gaps in diagnosis, potentially transforming outcomes for patients affected by this challenging disease.